Marked elevation of creatine phosphokinase alone caused by sintilimab - beware of hypothyroid myopathy

Title
Marked elevation of creatine phosphokinase alone caused by sintilimab - beware of hypothyroid myopathy
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CANCER
Volume 128, Issue -, Pages 57-59
Publisher
Elsevier BV
Online
2020-03-09
DOI
10.1016/j.ejca.2019.12.030

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now